Market Overview

UPDATE: Jefferies Upgrades Ventas to Buy; Both a Defensive and Growth Play

Share:
Related VTR
REIT Acquisitions Heat Up: Hospitals, Office Towers And Hotels Take Center Stage
BMO Capital's John Kim Explains Why Ventas Is A Healthcare REIT Worth Watching
3 Takeaways From Ventas' Second Quarter Conference Call (Seeking Alpha)

Jefferies upgraded Ventas (NYSE: VTR) from Hold to Buy and raised the price target from $66.00 to $72.00.

Jefferies commented, "Given macro uncertainties heading into 2013, VTR offers investors a nice mix of defense and growth. A solid acquisition outlook, and another year of strong results from the senior housing operating portfolio also suggests upside to 2013 consensus estimates. We are upgrading to Buy and raising our PT to $72 from $66."

Ventas closed at $64.76 on Monday.

Latest Ratings for VTR

DateFirmActionFromTo
Jul 2015BMO CapitalUpgradesMarket PerformOutperform
Jun 2015CitigroupMaintainsNeutral
Jun 2015CitigroupMaintainsNeutral

View More Analyst Ratings for VTR
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (VTR)

Get Benzinga's Newsletters